$2.58
0.031.18%
At close: -
$2.32
-0.26-10.08%
After Hours: Apr 4, 8:45 AM EDT
Comments
Loading...
Alpha Tau Medical Analyst Ratings and Price Targets | NASDAQ:DRTS | Benzinga
Alpha Tau Medical Ltd has a consensus price target of $11.75 based on the ratings of 4 analysts. The high is $23 issued by Cantor Fitzgerald on August 29, 2023. The low is $7 issued by Piper Sandler on August 15, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 17, 2025, November 22, 2024, and October 23, 2024, respectively. With an average price target of $9 between HC Wainwright & Co., there's an implied 287.93% upside for Alpha Tau Medical Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Piper Sandler
Citigroup
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Alpha Tau Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/17/2025 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 11/22/2024 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 10/23/2024 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2024 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/20/2024 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | 201.72% | Piper Sandler | Jason Bednar52% | $7 → $7 | Reiterates | Overweight → Overweight | Get Alert |
| 06/26/2024 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2024 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | $16 → $9 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2024 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | Buy Now | 201.72% | Piper Sandler | Jason Bednar52% | $8 → $7 | Reiterates | Overweight → Overweight | Get Alert |
| 12/15/2023 | Buy Now | 244.83% | Citigroup | Ashiq Mubarack36% | → $8 | Initiates | → Buy | Get Alert |
| 11/20/2023 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 11/17/2023 | Buy Now | 244.83% | Piper Sandler | Jason Bednar52% | $12 → $8 | Maintains | Overweight | Get Alert |
| 09/20/2023 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/29/2023 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/29/2023 | Buy Now | 891.38% | Cantor Fitzgerald | Kristen Kluska63% | → $23 | Reiterates | Overweight → Overweight | Get Alert |
| 08/18/2023 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2023 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 05/18/2023 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2023 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 04/24/2023 | Buy Now | 287.93% | HC Wainwright & Co. | Yi Chen54% | → $9 | Initiates | → Buy | Get Alert |
| 11/23/2022 | Buy Now | 417.24% | Piper Sandler | Jason Bednar52% | $19 → $12 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Alpha Tau Medical (DRTS) stock?
The latest price target for Alpha Tau Medical (NASDAQ:DRTS) was reported by HC Wainwright & Co. on March 17, 2025. The analyst firm set a price target for $9.00 expecting DRTS to rise to within 12 months (a possible 287.93% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alpha Tau Medical (DRTS)?
The latest analyst rating for Alpha Tau Medical (NASDAQ:DRTS) was provided by HC Wainwright & Co., and Alpha Tau Medical reiterated their buy rating.
When was the last upgrade for Alpha Tau Medical (DRTS)?
There is no last upgrade for Alpha Tau Medical
When was the last downgrade for Alpha Tau Medical (DRTS)?
There is no last downgrade for Alpha Tau Medical.
When is the next analyst rating going to be posted or updated for Alpha Tau Medical (DRTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on March 17, 2025 so you should expect the next rating to be made available sometime around March 17, 2026.
Is the Analyst Rating Alpha Tau Medical (DRTS) correct?
While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a reiterated with a price target of $9.00 to $9.00. The current price Alpha Tau Medical (DRTS) is trading at is $2.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.